TY - JOUR
T1 - Incidental Apical Pleuroparenchymal Scarring on Computed Tomography
AU - Toussie, Danielle
AU - Finkelstein, Mark
AU - Mendoza, Dexter
AU - Concepcion, Jose
AU - Stojanovska, Jadranka
AU - Azour, Lea
AU - Ko, Jane P.
AU - Moore, William H.
AU - Singh, Ayushi
AU - Sasson, Arielle
AU - Bhattacharji, Priya
AU - Eber, Corey
N1 - Publisher Copyright:
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2024/11/1
Y1 - 2024/11/1
N2 - Purpose: Apical pleuroparenchymal scarring (APPS) is commonly seen on chest computed tomography (CT), though the imaging and clinical features, to the best of our knowledge, have never been studied. The purpose was to understand APPS’s typical morphologic appearance and associated clinical features. Patients and Methods: A random generator selected 1000 adult patients from all 21516 chest CTs performed at urban outpatient centers from January 1, 2016 to December 31, 2016. Patients with obscuring apical diseases were excluded to eliminate confounding factors. After exclusions, 780 patients (median age: 64 y; interquartile range: 56 to 72 y; 55% males) were included for analysis. Two radiologists evaluated the lung apices of each CT for the extent of abnormality in the axial plane (mild: < 5 mm, moderate: 5 to 10 mm, severe: > 10 mm), craniocaudal plane (extension halfway to the aortic arch, more than halfway, vs below the arch), the predominant pattern (nodular vs reticular and symmetry), and progression. Cohen kappa coefficient was used to assess radiologists’ agreement in scoring. Ordinal logistic regression was used to determine associations of clinical and imaging variables with APPS. Results: APPS was present on 65% (507/780) of chest CTs (54% mild axial; 80% mild craniocaudal). The predominant pattern was nodular and symmetric. Greater age, female sex, lower body mass index, greater height, and white race were associated with more extensive APPS. APPS was not found to be associated with lung cancer in this cohort. Conclusion: Classifying APPS by the extent of disease in the axial or craniocaudal planes, in addition to the predominant pattern, enabled statistically significant associations to be determined, which may aid in understanding the pathophysiology of apical scarring and potential associated risks.
AB - Purpose: Apical pleuroparenchymal scarring (APPS) is commonly seen on chest computed tomography (CT), though the imaging and clinical features, to the best of our knowledge, have never been studied. The purpose was to understand APPS’s typical morphologic appearance and associated clinical features. Patients and Methods: A random generator selected 1000 adult patients from all 21516 chest CTs performed at urban outpatient centers from January 1, 2016 to December 31, 2016. Patients with obscuring apical diseases were excluded to eliminate confounding factors. After exclusions, 780 patients (median age: 64 y; interquartile range: 56 to 72 y; 55% males) were included for analysis. Two radiologists evaluated the lung apices of each CT for the extent of abnormality in the axial plane (mild: < 5 mm, moderate: 5 to 10 mm, severe: > 10 mm), craniocaudal plane (extension halfway to the aortic arch, more than halfway, vs below the arch), the predominant pattern (nodular vs reticular and symmetry), and progression. Cohen kappa coefficient was used to assess radiologists’ agreement in scoring. Ordinal logistic regression was used to determine associations of clinical and imaging variables with APPS. Results: APPS was present on 65% (507/780) of chest CTs (54% mild axial; 80% mild craniocaudal). The predominant pattern was nodular and symmetric. Greater age, female sex, lower body mass index, greater height, and white race were associated with more extensive APPS. APPS was not found to be associated with lung cancer in this cohort. Conclusion: Classifying APPS by the extent of disease in the axial or craniocaudal planes, in addition to the predominant pattern, enabled statistically significant associations to be determined, which may aid in understanding the pathophysiology of apical scarring and potential associated risks.
KW - apical pleuroparenchymal scarring
KW - chronic inflammation
KW - lung cancer
UR - http://www.scopus.com/inward/record.url?scp=85207594825&partnerID=8YFLogxK
U2 - 10.1097/RTI.0000000000000794
DO - 10.1097/RTI.0000000000000794
M3 - Article
C2 - 38798201
AN - SCOPUS:85207594825
SN - 0883-5993
VL - 39
SP - 376
EP - 384
JO - Journal of Thoracic Imaging
JF - Journal of Thoracic Imaging
IS - 6
ER -